Keros Therapeutics (KROS) Revenue (2019 - 2025)
Keros Therapeutics posted quarterly Revenue of $577000.0 for Q4 2025, up 213.58% year-on-year from $184002.5 in Q4 2024, and down 95.95% on a QoQ basis from $14.3 million in Q3 2025.
Keros Therapeutics (KROS) has 6 years of Revenue data on file, last reported at $577000.0 in Q4 2025.
- For the quarter ending Q4 2025, Revenue rose 213.58% year-over-year to $577000.0; the trailing twelve-month figure through Dec 2025 stood at $244.3 million (up 203644.17% YoY), and the FY2025 full-year result was $244.1 million, changed N/A from the prior year.
- Revenue for Q4 2025 stood at $577000.0, down from $14.3 million in the prior quarter.
- Across five years, Revenue topped out at $211.2 million in Q1 2025 and bottomed at -$508000.0 in Q4 2024.
- The 5-year median for Revenue is $577000.0 (2025), against an average of $25.5 million.
- Peak annual rise in Revenue reached 4750.0% in 2024, while the deepest fall reached 455.24% in 2024.
- A 5-year view of Revenue shows it stood at $17.9 million in 2021, then increased by 0.56% to $18.0 million in 2022, then sank by 99.21% to $143000.0 in 2023, then plunged by 455.24% to -$508000.0 in 2024, then surged by 213.58% to $577000.0 in 2025.
- The last three Revenue figures came in at $577000.0 (Q4 2025), $14.3 million (Q3 2025), and $18.2 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 306.30 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 2.99 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.61 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.17 Bn |
| 10 | Keros Therapeutics | 403.85 Mn | 116.45 Mn | - | 577,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 577,000.00 |
| Sep 30, 2025 | 14.26 Mn |
| Jun 30, 2025 | 18.17 Mn |
| Mar 31, 2025 | 211.25 Mn |
| Dec 31, 2024 | -508,000.00 |
| Sep 30, 2024 | 388,000.00 |
| Dec 31, 2023 | 143,000.00 |
| Sep 30, 2023 | 8,000.00 |
| Mar 31, 2022 | 18.00 Mn |
| Dec 31, 2021 | 17.90 Mn |
| Jun 30, 2021 | 100,000.00 |
| Dec 31, 2019 | 2.50 Mn |
| Sep 30, 2019 | 2.50 Mn |
| Jun 30, 2019 | 2.50 Mn |
| Mar 31, 2019 | 2.50 Mn |